| Bioactivity | Diacetazotol inhibits dioxin-induced ethoxyresorufin-O-deethylase (EROD) activity with IC50 of 75±4 nM. Diacetazotol extracts from patent US20070032458, compound 3. | ||||||||||||
| Target | IC50: 75±4 nM (Dioxin-induced EROD activity) | ||||||||||||
| Invitro | Diacetazotol has activity for inhibiting dioxin toxicity[1]. | ||||||||||||
| Name | Diacetazotol | ||||||||||||
| CAS | 83-63-6 | ||||||||||||
| Formula | C18H19N3O2 | ||||||||||||
| Molar Mass | 309.36 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Pann Suh, et al. Compound having activity for inhibiting dioxin toxicity, pharmaceutical composition comprising the compound and method for treating disease resulting from dioxin toxicity using the compound .US 20070032458 A1. |